Skip to main content
Therapeutic Advances in Neurological Disorders logoLink to Therapeutic Advances in Neurological Disorders
. 2018 Mar 21;11:1756286418765591. doi: 10.1177/1756286418765591

Corrigendum

PMCID: PMC5865453  PMID: 29595827

Abstract

Mantegazza R and Antozzi C. When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Ther Adv Neurol Disord. 2018; 11: 1–11. DOI: 10.1177/1756285617749134


In this article, Figure 1 was not correct. The correct figure is shown below:

graphic file with name 10.1177_1756286418765591-img1.jpg

The change has been made to all subsequent versions of the article.


Articles from Therapeutic Advances in Neurological Disorders are provided here courtesy of SAGE Publications

RESOURCES